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 Chapter 19 
 STC-1 Cells 
 Triona  McCarthy ,  Brian  D.  Green ,  Danielle  Calderwood ,  Anna  Gillespie , 
 John  F.  Cryan , and  Linda  Giblin 
 Abstract  Gastrointestinal hormones such as cholecystokinin (CCK), glucagon like 
peptide 1 (GLP-1), and peptide YY (PYY) play an important role in suppressing 
hunger and controlling food intake. These satiety hormones are secreted from 
enteroendocrine cells present throughout the intestinal tract. The intestinal secretin 
tumor cell line (STC-1) possesses many features of native intestinal enteroendo-
crine cells. As such, STC-1 cells are routinely used in screening platforms to 
identify foods or compounds that modulate secretion of gastrointestinal hormones 
in vitro. This chapter describes this intestinal cell model focussing on it’s applica-
tions, advantages and limitations. A general protocol is provided for challenging 
STC-1 cells with test compounds. 
 Keywords  Enteroendocrine cells •  Secretin tumor cell line (STC-1) •  Satiety 
 hormones •  GLP-1 •  CCK •  PYY •  Food components •  G protein coupled receptors 
•  Nutrient sensing 
19.1  Origin 
 STC-1 was originally established from cells present in murine enteroendocrine 
tumours. These tumours arose in the duodenum of double transgenic mice express-
ing the rat insulin promoter linked to the simian virus 40 large T antigen and to the 
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polyomavirus small T antigen (Rindi et al.  1990 ). STC-1 is a relatively slow growing 
cell line, with a doubling time of 54 h in standard growth media. They are not easily 
amenable to transfection with several studies reporting low transfection effi ciencies 
(stable and transient). Under culturing conditions, this cell line is heterogenous. 
However most subpopulations demonstrate immunoreactivity to the gut hormone, 
cholecystokinin (CCK) (Rindi et al.  1990 ). As such, STC-1 cells were originally 
used as a model of native CCK-producing I-cells. Over the past two decades, the 
uses of the STC-1 cell line has been expanded to investigate (a) the cellular signal-
ing mechanisms involved in secretion and gene transcription of other gut hormones 
(Cordier-Bussat et al. 1998; Geraedts et al.  2009 ), (b) enteroendocrine cell differen-
tiation (Ratineau et al.  1997 ), (c) tumor cell growth (Bollard et al.  2013 ) and (d) 
intestinal immune responses (Palazzo et al.  2007 ). 
19.2  Features and Mechanisms 
 In addition to CCK, STC-1 cells express and secrete a wide range of gut hormones 
known for their roles in metabolism, feeding and satiety, including glucose depen-
dent insulinotropic polypeptide (GIP), peptide YY (PYY), pancreatic polypeptide, 
neurotensin and the proglucagon derived peptides [glucogon-like peptide-1 (GLP-1), 
glucogon-like peptide-2 (GLP-2) and oxyntomodulin] (Rindi et al.  1990 ; Hand 
et al.  2013 ). STC-1 cells secrete these hormones in response to a range of physio-
logical stimuli, although levels may differ to native enteroendocrine cells (Reimann 
et al.  2008 ). This ability to secrete a variety of gut hormones ensures that the STC-1 
cell line remains a popular ‘look-see’ choice with food researchers. 
 Monosaccharides (Mangel et al.  1994 ), fatty acids (Hand et al.  2010 ), aromatic 
amino acids (Cordier-Bussat 1998; Wang et al.  2011 ), peptidomimetic compounds 
(Geraedts et al.  2011 ) and bitter tastants (Miyata et al.  2014 ) have all been demon-
strated to dose dependently elicit CCK and GLP-1 secretion from STC-1 cells. 
Several studies have also reported that sucralose and other sweeteners increase 
CCK and GLP-1 secretion in STC-1 cells (Geraedts et al.  2012 ). Interestingly, these 
substances do not appear to be GLP-1 stimulants in primary cultures of murine 
intestinal epithelium (Reimann et al.  2008 ). Although PYY secretion has been less 
widely investigated, STC-1 cells reliably produce and secrete PYY in response to a 
variety of fatty acids including valeric acid, linoleic acid and conjugated linoleic 
acid 9,11 (Hand et al.  2013 ). GIP expression and production by STC-1 cells is poor. 
Nevertheless as there are few in vitro alternatives, GIP subclones of STC-1 cells 
with increased  GIP expression have been generated (Kieffer et al.  1995 ). 
 Several neural and hormonal stimuli which play an important role in coordinat-
ing early responses to food ingestion in vivo also induce gut peptide release from 
STC-1 cells. These include the neurotransmitters gamma-aminobutyric acid 
(GABA), acetylcholine, orexin, bombesin, apelin, gastrin releasing peptide as well 
as bile acids and leptin. 
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 Hormone secretion from this cell line appears to be dependent on a rise in 
 cytoplasmic cAMP and Ca 2+ which ultimately leads to alteration in hormone gene 
transcription levels or hormone peptide release. Increased Ca 2+ levels can occur as a 
result of (a) an infl ux of Ca 2+ across the plasma membrane through activation of 
voltage- gated calcium channels or (b) inositol 1,4,5-triphosphate (IP3) triggered 
Ca 2+ release from intracellular stores. In native enteroendocrine cells, intracellular 
levels of Ca 2+ and cAMP are also altered by the activity of a number of G-protein 
coupled receptors (GPCR’s) and nutrient transporters. STC-1 cells have been found 
to intrinsically express many of these important GPCRs including GPR40 and 
GPR120 (Tanaka et al.  2008 ). Hormone secretion is dependent on GPR40 in native 
murine I-cells, as linolenic acid induced CCK secretion was absent in cells lacking 
this receptor (Liou et al.  2011b ). In contrast, GPR40 knockdown had little effect on 
the ability of STC-1 cells to sense fatty acids. Rather, it is GPR120 that appears to 
play a more important role in fatty acid sensing in STC-1 cells. Fatty acid-induced 
hormone release is impaired in  GPR120 siRNA silencing experiments (Tanaka et al. 
 2008 ). Wang  et al . demonstrated that phenylalanine induced Ca 2+ mobilization and 
hormone secretion occurs via the calcium-sensing receptor which is highly 
expressed in native murine enteroendocrine cells (Wang et al.  2011 ). This receptor 
is however poorly expressed in STC-1 cells, although it is functional. Several taste 
signalling elements such as alpha-gustducin, phospholipase C-β2, transient receptor 
potential channel M5 and the taste receptor T1R/T2R subunits are present and func-
tional in STC-1 cells similar to native enteroendocrine cells (Dyer et al.  2005 ). 
 Recent evidence suggests that ATP-sensitive K + channels and transporters [e.g. 
sodium-coupled glucose transporters (SGLTs) and peptide transporters (PEPTs)] 
contribute to hormone secretion in enteroendocrine cells (Tolhurst et al.  2009 ). 
However STC-1 cells express low levels of the K ATP channel subunits, Kir6.2 and 
SUR1. Endogenous expression of PEPTs is also poor in STC-1 cells (Liou et al. 
 2011a ). 
 In addition to stimulating gut hormone release, common luminal nutrients added 
to the growth media are also capable of modulating gene expression in STC-1 cells. 
As such this cell line has been widely used to investigate the regulation of  CCK 
gene expression. However, for the  proglucagon gene, aberrant posttranslational 
 processing has been documented (Blache et al.  1994 ). In vivo, the synthesis of 
proglucagon- derived peptides is tissue specifi c due to the action of various prohor-
mone convertase enzymes (e.g. PC1/3). In pancreatic α cells, posttranslational pro-
cessing of proglucagon liberates glucagon, glicentin-related pancreatic peptide, and 
the major proglucagon fragment, which contains the sequences for both GLP-1 and 
GLP-2. In contrast, processing of proglucagon in the intestinal enteroendocrine 
L-cell generates GLP-1 and GLP-2, as well as the glucagon-containing peptides, 
glicentin and oxyntomodulin. Blache  et al . reported that proglucagon processing in 
STC-1 cells results in the production of signifi cant quantities of glucagon in addition 
to glicentin and oxyntomodulin (Blache et al.  1994 ). Thus STC-1 cells appear to 
process the proglucagon fragment in a manner which is intermediate between 
intestinal L-cells and pancreatic α cells. 
19 STC-1 Cells
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19.3  Stability, Consistency and Reproducibility 
 When used appropriately, STC-1 cell line has been shown to be a reliable and repro-
ducible enteroendocrine cell model. However, considerable variances in hormone 
secretion levels have been reported by different laboratories for the same substance 
(Geraedts et al.  2009 ; Hand et al.  2013 ). For example, Cordier-Bussat  et al . showed 
that addition of protein hydrolysates from meat, casein and soybean to STC-1 cells 
increased CCK and GLP-1 release compared to undigested proteins (Cordier-Bussat 
et al.  1997 ). In contrast, other studies have demonstrated that intact protein is a 
much stronger stimulant for CCK and GLP-1 release in STC-1 cells than hydroly-
sates or specifi c peptides (Geraedts et al.  2011 ). In addition to differences between 
different laboratories, signifi cant inter-experimental variability in the amount of 
CCK secreted has also been reported within study groups. Differences in culture 
protocols such as seeding density, cell feeding routine, washing steps, test buffer 
and passage number may account in part for this variability. However, inter- 
experimental variability is most likely a direct result of the heterogenous non-stable 
nature of the cell line. Cultured STC-1 cells demonstrate 95 % immunoreactivity to 
CCK, while only 7 % stain positively for GIP (Rindi et al.  1990 ). Glassmeier  et al . 
reported that the sensitivity of STC-1 cells to the neurotransmitter GABA varied 
considerably from cell to cell, due to the heterogeneous density and expression of 
GABA A receptors in this cell line (Glassmeier et al.  1998 ). STC-1 cells may switch 
to multiple differentiated states during proliferation (Rindi et al.  1990 ). Consequently 
levels of hormone secretion may signifi cantly differ from one test to another. 
To improve the homogeneity and the stability of STC-1 cells, several studies have 
attempted to isolate and characterize clonal cell lines from parental STC-1 cells. 
However even these cells do not express a stable phenotype. For example, while 
attempting to clone a pure GIP-expressing cell, Kieffer  et al . observed that only 
30 % of the expanded clone still expressed GIP immunoreactivity due to dediffer-
entiation of the cells (Kieffer et al.  1995 ). These observations highlight the impor-
tance of including adequate controls and replicates for each independent experiment. 
As early passage number STC-1 cells have greater heterogeneity, cells that have 
been passaged more than 10 times are recommended. It also underlines the impor-
tance of verifying results with experiments independent of STC-1 cells. 
19.4  Relevance to Human In Vivo Situation 
 A major requirement of any in vitro model is that it should demonstrate a strong 
predictive power, yielding data that support interpretation of results for the in vivo 
situation. Although STC-1 cells do respond to a range of physiological stimuli 
shown to elicit gut hormone secretion in vivo, some inconsistencies have been 
observed. Hall  et al . demonstrated that while whey consumption in humans resulted 
in a greater increase in GLP-1, GIP, and CCK plasma levels compared to other pro-
tein sources (Hall et al.  2003 ), whey protein hydrolysate are ineffective stimulants 
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of CCK release in STC-1 cells (Foltz et al.  2008 ). STC-1 and the native state also 
differ in PYY secretion to fatty acids (Hand et al.  2013 ). 
 In vivo gut hormone release occurs through direct sensing of luminal nutrients 
but also indirectly by vagal and humoral stimulation (Gribble  2012 ). Evidence 
shows that the release of bile acids, gastric acid secretions, mechanical stimula-
tion by peristaltic contractions, gastric emptying and hormonal stimulation all 
result in gut hormone modulation. While STC-1 cells harbour many features of 
native intestinal hormone secreting cells, they are cultivated as monolayers on 
plastic surfaces and lack a normal cellular environment. They therefore cannot 
reproduce the integrative physiological interplay present in vivo. Thus many 
components which stimulate gut hormone secretion through indirect mechanisms 
will not be detected by this model. A typical example of this limitation is that 
potato protease inhibitors fail to elevate CCK expression or release in STC-1 cells 
(Komarnytsky et al.  2011 ). However in vivo potato protease inhibitors reduce 
food intake, and increase plasma and duodenal mucosal mRNA levels of  CCK in 
rats indirectly by inhibiting trypsin mediated deactivation of endogenously pro-
duced CCK releasing factors (Komarnytsky et al.  2011 ). 
 It is also worth noting that compounds which elicit gut hormone secretion from 
STC-1 cells and in vivo, do not always effect food intake or the perception of the 
feeling of fullness. For example, Korean pine nut oil effectively increases CCK 
secretion from STC-1 cells and in plasma levels of humans. This increase in satiety 
hormone levels however did not correspond to a change in subjective appetite sensa-
tions as assessed by visual analogue scales (Pasman et al.  2008 ). This lack of rela-
tionship between increased plasma concentrations of gut hormones and appetite 
ratings has been observed in other studies (Veldhorst et al.  2009 ). 
19.5  General Protocol 
19.5.1  Cell Maintenance Protocol 
 STC-1 cells should be cultured in supplemented DMEM media (DMEM containing 
4.5 g/l  D -glucose, without sodium pyruvate) (GlutaMAX, GIBCO, Paisley, UK) 
with 17.5 % foetal bovine serum (FBS), 100 U/ml penicillin, 100 mg/l streptomycin 
and incubated in a 5 % CO 2 humidifi ed atmosphere at 37 °C. Cells should be pas-
saged at 80–90 % confl uence. Passage number should be between 15 and 40. 
19.5.2  Experimental Protocol for Test Compounds 
 Test compounds should be prepared in pre-warmed buffer. Buffer should be tested 
to ensure compatibility with the particular immunoassay. 
19 STC-1 Cells
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 Figure  19.1 indicates that dramatically different results can be obtained depending 
on the buffer system used. Use of buffer solutions which are highly stimulatory 
(e.g. DMEM media which contains amino acids and vitamins), should be avoided 
because hormone levels for vehicle controls will be greatly elevated and can distort 
results. In previous experiments, we have favoured KREBS buffer. The test solution 
pH should be adjusted to 7.0–7.4 and fi lter sterilised (0.45 μm fi lter). If solubility of 
test compounds is an issue (e.g. in the case of lipids or fatty acids) careful monitor-
ing is needed to ensure test compounds remain in solution for the duration of experi-
ments. To measure acute hormone secretion, STC-1 cells should be seeded into 6 well 
plates at 1.5 × 10 6 cells in supplemented DMEM media. After 18 h at 37 °C in 5 % 
CO 2, media should be aspirated and cell monolayers washed 1–2 times with selected 
buffer. The cells should be acclimatised in buffer for 1 h. Culture media and wash 
buffers can be kept to ensure that cells have reached basal levels of hormone secre-
tion (Fig.  19.1 ). After 1 h, the buffer is aspirated and 1 ml test solution added to 
wells. Cells are then incubated for 1–4 h at 37 °C, 5 % CO 2 (in our experience a 
period of 3–4 h is optimal for hormone secretion, Fig.  19.2 ). Positive controls 
known to stimulate gut hormone secretion and negative controls (buffer alone) 
 Fig. 19.1  Effect of various incubation buffers on levels of Total GLP-1 secreted from STC-1 cells. 
STC-1 cells (2 × 10 6 ) were challenged with mixed nutrients [glutamine + valine + lysine + gly-
cine + glucose + fructose (all at 40 mM)] for 3 h. Samples were prepared in PBS or HANKS or 
KREBS or HEPES buffers or DMEM media (GlutaMAX, GIBCO, Paisley, UK). The composition 
of the buffers are as follows; PBS (136.9 mM NaCl, 2.7 mM KCl, 10.1 mM Na 2 HPO 4 , 1.8 mM 
KH 2 PO 4 ), HANKS (136.9 mM NaCl, 5.4 mM KCl, 1.3 mM CaCl 2 , 1 mM MgSO 4 , 0.2 mM 
NaHPO 4 , 0.4 mM KH 2 PO 4 , 4.2 mM NaHCO 3 , 5.6 mM glucose), KREBS (118 mM NaCl, 4.7 mM 
KCl, 25 mM NaHCO 3 , 1.25 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 11 mM glucose) and 
HEPES (140 mM NaCl, 4.5 mM KCl, 1.2 mM CaCl 2 , 1.2 mM MgCl 2 , 20 mM HEPES). Total 
GLP-1 was measured by a specifi c GLP-1 radioimmunoassay. Statistical comparisons (unpaired 
Student’s t-test) were only performed on 3 h incubations with or without nutrient challenge for 
each selected buffer. Signifi cant differences are indicated on the graph (*P < 0.05) 
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should always be included in each experimental unit. Post-incubation, we recom-
mend the addition of 10 μl 10X Halt Protease and Phosphatase Inhibitor (Thermo 
Fisher Scientifi c, USA) to protect against gut hormone degradation. Cellular super-
natants are collected and store at −80 °C prior to further analysis. It is best practice 
to immediately transfer solutions to tubes placed on ice and to centrifugate (900× g 
for 5 min) to remove cellular debris. At least three biological replicates should be 
performed. 
19.6  Assess Viability 
 Prior to hormone studies, viability or integrity of STC-1 cells challenged with test 
compounds at various concentrations should be tested. Where test compounds are 
digested, viability tests should be performed with the inactivated and pH adjusted 
(7.0–7.4) digestion matrix. An array of methods and kit-based assays are available 
for cell viability (e.g. measurement of mitochondrial reductase with tetrazolium 
salts, measurement of cell membrane integrity or signs of cytolysis and/or detection 
of increased apoptosis). Due the ability of healthy STC-1 cells to change morphol-
ogy and grow extensions, systems based on electrical impedance may be unsuitable 
for such tests. 
400 Incubation time
1h
2h
3h
4h300
200
100
T
o
ta
l G
L
P
 -
1 
S
ec
re
te
d
 (
r 
m
o
le
s)
0
Ve
hic
le 
Co
nt
ro
l
Ve
hic
le 
Co
nt
ro
l
Ve
hic
le 
Co
nt
ro
l
Ve
hic
le 
Co
nt
ro
l
Am
ino
 a
cid
s
Am
ino
 a
cid
s
Am
ino
 a
cid
s
Am
ino
 a
cid
s
M
on
os
ac
ch
ar
ide
s
M
on
os
ac
ch
ar
ide
s
M
on
os
ac
ch
ar
ide
s
M
on
os
ac
ch
ar
ide
s
Test Samples
 Fig. 19.2  Determining the optimal incubation time to measure levels of Total GLP-1 secreted 
from STC-1 cells. STC-1 cells (2 × 10 6 ) were exposed for various incubation times with stimula-
tory amino acid solution (40 mM glutamine, 40 mM valine, 40 mM lysine and 40 mM glycine) and 
monosaccharide solution (40 mM glucose and 40 mM fructose) which were prepared in HEPES 
buffer. Data were statistically compared using the unpaired Student’s t-test and signifi cant differ-
ences to vehicle controls are indicated *P < 0.05, **P < 0.01 and ***P < 0.001 
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19.7  Experimental Read out 
 Intracellular levels of the secondary messengers (cAMP, IP3 and Ca 2+ ) are often used 
as rapid indirect indicators of gut hormone secretion. Several types of assays are cur-
rently available to measure cAMP including radioimmunoassay approaches, time-
resolved FRET-bioluminescence resonance energy transfer based assays, enzyme 
fragmentation complementation and cyclic nucleotide gated ion channel coupled 
assays. Intracellular Ca 2+ concentrations can be determined directly using membrane 
permanent calcium-sensitive dyes (e.g. Fluo-3, Fluo-4 or Fura-2) that fl uoresce upon 
exposure to free Ca 2+ . IP1, a downstream metabolite of IP3, can be used as a surro-
gate for direct determination of Ca 2+ as it has a longer half-life. A competitive immu-
noassay is commercially available that uses terium cryptate- labeled anti-IP1 and D2 
labeled IP1 (Cisbso Bioassays, France). IP1 levels only refl ect release of Ca 2+ from 
intracellular stores and do not account for increased Ca 2+ levels resulting from infl ux 
across the cellular membrane. 
 Specifi c assays for individual hormones include qRT-PCR assays and immuno-
assays (ELISA and RIA). For qRT-PCR, standard methods apply. Result interpreta-
tion is important as increases in mRNA levels and intracellular peptide levels may 
not result in corresponding increases in secretion levels of gut peptides (Hand et al. 
 2010 ). A number of sensitive and accurate commercial immunoassays (ELISA and 
RIA) are available for the detection of CCK, PYY and GLP-1, although multiplex-
ing these analytes has proved diffi cult. Antibodies may not discriminate between 
bioactive and inactive forms of gut peptides. Moreover, a large cross-reactivity with 
gastrin has been observed for many commercially available assays. To overcome 
these limitations Foltz  et al . developed an assay based on the ability of dietary com-
ponents to induce CCK release from STC-1 cells and in turn activate the CCK 
receptor overexpressed in the chinese hamster ovary cell line (Foltz et al.  2008 ). 
Upon activation of the CCK receptor, Ca 2+ levels increase, which can be visualized 
with a fl uorescent dye. Thus this assay rapidly and directly determines the effect of 
a nutritional intervention on activation of CCK receptor yielding results which are 
more physiological relevant. 
19.8  Conclusions 
 The murine STC-1 cell line is regarded as ‘best in class’ to evaluate secretion of 
several satiety hormones in response to food components in vitro. The gut hormones 
CCK, GLP-1, GIP, PYY, pancreatic polypeptide, neurotensin, GLP-2 and oxynto-
modulin are all secreted by STC-1 cells. However the heterogeneous nature of STC-1 
cells can introduce discrepancies from experiment to experiment. In addition, it’s 
response to stimulants can vary from the native enteroendocrine cell which underlines 
the importance of substantiating results in vivo. 
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